{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:40:05Z","timestamp":1775151605643,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T00:00:00Z","timestamp":1287014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2334-10-295","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T14:15:15Z","timestamp":1287152115000},"source":"Crossref","is-referenced-by-count":36,"title":["The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents"],"prefix":"10.1186","volume":"10","author":[{"given":"Sadeep","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Staci L","family":"Sudenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura H","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig M","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam C","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,14]]},"reference":[{"issue":"11","key":"1275_CR1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","volume":"87","author":"FX Bosch","year":"1995","unstructured":"Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995, 87 (11): 796-802. 10.1093\/jnci\/87.11.796.","journal-title":"J Natl Cancer Inst"},{"issue":"6 Suppl 1","key":"1275_CR2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.ogx.0000221010.82943.8c","volume":"61","author":"D Wiley","year":"2006","unstructured":"Wiley D, Masongsong E: Human papillomavirus: the burden of infection. Obstet Gynecol Surv. 2006, 61 (6 Suppl 1): S3-14. 10.1097\/01.ogx.0000221010.82943.8c.","journal-title":"Obstet Gynecol Surv"},{"issue":"8","key":"1275_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.297.8.813","volume":"297","author":"EF Dunne","year":"2007","unstructured":"Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE: Prevalence of HPV infection among females in the United States. Jama. 2007, 297 (8): 813-819. 10.1001\/jama.297.8.813.","journal-title":"Jama"},{"issue":"1","key":"1275_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1363\/3600604","volume":"36","author":"H Weinstock","year":"2004","unstructured":"Weinstock H, Berman S, Cates W: Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004, 36 (1): 6-10. 10.1363\/3600604.","journal-title":"Perspect Sex Reprod Health"},{"issue":"12","key":"1275_CR5","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","volume":"151","author":"ER Myers","year":"2000","unstructured":"Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB: Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000, 151 (12): 1158-1171.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1275_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1363\/3601104","volume":"36","author":"HW Chesson","year":"2004","unstructured":"Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL: The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health. 2004, 36 (1): 11-19. 10.1363\/3601104.","journal-title":"Perspect Sex Reprod Health"},{"issue":"7","key":"1275_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJM199802123380703","volume":"338","author":"GY Ho","year":"1998","unstructured":"Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998, 338 (7): 423-428. 10.1056\/NEJM199802123380703.","journal-title":"N Engl J Med"},{"issue":"2","key":"1275_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0022-3476(98)70445-7","volume":"132","author":"AB Moscicki","year":"1998","unstructured":"Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, et al: The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998, 132 (2): 277-284. 10.1016\/S0022-3476(98)70445-7.","journal-title":"J Pediatr"},{"issue":"7","key":"1275_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jnci\/djn044","volume":"100","author":"AC Rodriguez","year":"2008","unstructured":"Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, Castle PE, Solomon D, Burk R: Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst. 2008, 100 (7): 513-517. 10.1093\/jnci\/djn044.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"1275_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/00007435-199805000-00005","volume":"25","author":"KL Kotloff","year":"1998","unstructured":"Kotloff KL, Wasserman SS, Russ K, Shapiro S, Daniel R, Brown W, Frost A, Tabara SO, Shah K: Detection of genital human papillomavirus and associated cytological abnormalities among college women. Sex Transm Dis. 1998, 25 (5): 243-250. 10.1097\/00007435-199805000-00005.","journal-title":"Sex Transm Dis"},{"issue":"2","key":"1275_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/aje\/kwj165","volume":"164","author":"J Koshiol","year":"2006","unstructured":"Koshiol J, Schroeder J, Jamieson DJ, Marshall SW, Duerr A, Heilig CM, Shah KV, Klein RS, Cu-Uvin S, Schuman P, et al: Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women. Am J Epidemiol. 2006, 164 (2): 176-183. 10.1093\/aje\/kwj165.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1275_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1386-6532(01)00172-X","volume":"22","author":"M Lehtinen","year":"2001","unstructured":"Lehtinen M, Luukkaala T, Wallin KL, Paavonen J, Thoresen S, Dillner J, Hakama M: Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction. J Clin Virol. 2001, 22 (1): 117-124. 10.1016\/S1386-6532(01)00172-X.","journal-title":"J Clin Virol"},{"issue":"12","key":"1275_CR13","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/oxfordjournals.aje.a010165","volume":"151","author":"L Ahdieh","year":"2000","unstructured":"Ahdieh L, Munoz A, Vlahov D, Trimble CL, Timpson LA, Shah K: Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol. 2000, 151 (12): 1148-1157.","journal-title":"Am J Epidemiol"},{"issue":"19","key":"1275_CR14","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJM199711063371903","volume":"337","author":"XW Sun","year":"1997","unstructured":"Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC: Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997, 337 (19): 1343-1349. 10.1056\/NEJM199711063371903.","journal-title":"N Engl J Med"},{"issue":"7","key":"1275_CR15","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/ijc.22015","volume":"119","author":"JE Koshiol","year":"2006","unstructured":"Koshiol JE, Schroeder JC, Jamieson DJ, Marshall SW, Duerr A, Heilig CM, Shah KV, Klein RS, Cu-Uvin S, Schuman P, et al: Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer. 2006, 119 (7): 1623-1629. 10.1002\/ijc.22015.","journal-title":"Int J Cancer"},{"issue":"1","key":"1275_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1086\/421467","volume":"190","author":"AB Moscicki","year":"2004","unstructured":"Moscicki AB, Ellenberg JH, Farhat S, Xu J: Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis. 2004, 190 (1): 37-45. 10.1086\/421467.","journal-title":"J Infect Dis"},{"issue":"5","key":"1275_CR17","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S0002-9378(98)70535-6","volume":"178","author":"H Minkoff","year":"1998","unstructured":"Minkoff H, Feldman J, DeHovitz J, Landesman S, Burk R: A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol. 1998, 178 (5): 982-986. 10.1016\/S0002-9378(98)70535-6.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"1275_CR18","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1086\/323081","volume":"184","author":"L Ahdieh","year":"2001","unstructured":"Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, Safaeian M, Astemborski J, Daniel R, Shah K: Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis. 2001, 184 (6): 682-690. 10.1086\/323081.","journal-title":"J Infect Dis"},{"issue":"12","key":"1275_CR19","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/jnci\/djm010","volume":"99","author":"RJ Biggar","year":"2007","unstructured":"Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA: AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007, 99 (12): 962-972. 10.1093\/jnci\/djm010.","journal-title":"J Natl Cancer Inst"},{"key":"1275_CR20","doi-asserted-by":"crossref","unstructured":"Bratcher LF, Sahasrabuddhe VV: The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Infect Agent Cancer. 5: 8-10.1186\/1750-9378-5-8.","DOI":"10.1186\/1750-9378-5-8"},{"issue":"12","key":"1275_CR21","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1097\/00002030-199812000-00007","volume":"12","author":"I Heard","year":"1998","unstructured":"Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD: Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. Aids. 1998, 12 (12): 1459-1464. 10.1097\/00002030-199812000-00007.","journal-title":"Aids"},{"issue":"13","key":"1275_CR22","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1097\/00002030-200209060-00013","volume":"16","author":"I Heard","year":"2002","unstructured":"Heard I, Tassie JM, Kazatchkine MD, Orth G: Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. Aids. 2002, 16 (13): 1799-1802. 10.1097\/00002030-200209060-00013.","journal-title":"Aids"},{"issue":"16","key":"1275_CR23","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1097\/00002030-200111090-00011","volume":"15","author":"H Minkoff","year":"2001","unstructured":"Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, Muderspach L, Burk R, Palefsky J: The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. Aids. 2001, 15 (16): 2157-2164. 10.1097\/00002030-200111090-00011.","journal-title":"Aids"},{"issue":"14","key":"1275_CR24","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/jnci\/djh192","volume":"96","author":"L Ahdieh-Grant","year":"2004","unstructured":"Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, et al: Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2004, 96 (14): 1070-1076. 10.1093\/jnci\/djh192.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1275_CR25","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1067\/mob.2001.111103","volume":"184","author":"WR Robinson","year":"2001","unstructured":"Robinson WR, Hamilton CA, Michaels SH, Kissinger P: Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. Am J Obstet Gynecol. 2001, 184 (4): 538-543. 10.1067\/mob.2001.111103.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1275_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1086\/322856","volume":"184","author":"FB Lillo","year":"2001","unstructured":"Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, Mastrorilli E, Taccagni G, Lazzarin A, Uberti-Foppa C: Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis. 2001, 184 (5): 547-551. 10.1086\/322856.","journal-title":"J Infect Dis"},{"issue":"5","key":"1275_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1086\/381681","volume":"38","author":"A Del Mistro","year":"2004","unstructured":"Del Mistro A, Bertorelle R, Franzetti M, Cattelan A, Torrisi A, Giordani MT, Sposetti R, Bonoldi E, Sasset L, Bonaldi L, et al: Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women. Clin Infect Dis. 2004, 38 (5): 737-742. 10.1086\/381681.","journal-title":"Clin Infect Dis"},{"issue":"14","key":"1275_CR28","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1097\/00002030-200309260-00021","volume":"17","author":"C Uberti-Foppa","year":"2003","unstructured":"Uberti-Foppa C, Ferrari D, Lodini S, Reina S, Ameglio F, Grasso MA, Gallotta G, Ferrari A, Taccagni G, Lazzarin A, et al: Long-term effect of highly active antiretroviral therapy on cervical lesions in HIV-positive women. Aids. 2003, 17 (14): 2136-2138. 10.1097\/00002030-200309260-00021.","journal-title":"Aids"},{"issue":"1","key":"1275_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/AOG.0b013e31819225cb","volume":"113","author":"P Paramsothy","year":"2009","unstructured":"Paramsothy P, Jamieson DJ, Heilig CM, Schuman PC, Klein RS, Shah KV, Rompalo AM, Cu-Uvin S, Duerr A: The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol. 2009, 113 (1): 26-31.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"1275_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/CEJ.0b013e3282f75ea1","volume":"17","author":"H De Vuyst","year":"2008","unstructured":"De Vuyst H, Lillo F, Broutet N, Smith JS: HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev. 2008, 17 (6): 545-554. 10.1097\/CEJ.0b013e3282f75ea1.","journal-title":"Eur J Cancer Prev"},{"issue":"3 Suppl","key":"1275_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S1054-139X(01)00291-9","volume":"29","author":"CM Wilson","year":"2001","unstructured":"Wilson CM, Houser J, Partlow C, Rudy BJ, Futterman DC, Friedman LB: The REACH (Reaching for Excellence in Adolescent Care and Health) project: study design, methods, and population profile. J Adolesc Health. 2001, 29 (3 Suppl): 8-18. 10.1016\/S1054-139X(01)00291-9.","journal-title":"J Adolesc Health"},{"issue":"17","key":"1275_CR32","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1097\/00002030-200211220-00007","volume":"16","author":"J Tang","year":"2002","unstructured":"Tang J, Wilson CM, Meleth S, Myracle A, Lobashevsky E, Mulligan MJ, Douglas SD, Korber B, Vermund SH, Kaslow RA: Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents. Aids. 2002, 16 (17): 2275-2284. 10.1097\/00002030-200211220-00007.","journal-title":"Aids"},{"issue":"4","key":"1275_CR33","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S1054-139X(97)00279-6","volume":"22","author":"AS Rogers","year":"1998","unstructured":"Rogers AS, Futterman DK, Moscicki AB, Wilson CM, Ellenberg J, Vermund SH: The REACH Project of the Adolescent Medicine HIV\/AIDS Research Network: design, methods, and selected characteristics of participants. J Adolesc Health. 1998, 22 (4): 300-311. 10.1016\/S1054-139X(97)00279-6.","journal-title":"J Adolesc Health"},{"issue":"5","key":"1275_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.7326\/0003-4819-137-5_Part_2-200209031-00001","volume":"137","author":"M Dybul","year":"2002","unstructured":"Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK: Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV. Annals of Internal Medicine. 2002, 137 (5): 381-433.","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"1275_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/09540120020018161","volume":"13","author":"DA Murphy","year":"2001","unstructured":"Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M: Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2001, 13 (1): 27-40. 10.1080\/09540120020018161.","journal-title":"AIDS Care"},{"issue":"2","key":"1275_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/archpedi.154.2.127","volume":"154","author":"AB Moscicki","year":"2000","unstructured":"Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM: Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med. 2000, 154 (2): 127-134.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1275_CR37","unstructured":"Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2007, 90: 1-636."},{"issue":"4","key":"1275_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, et al: A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009, 10 (4): 321-322. 10.1016\/S1470-2045(09)70096-8.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1275_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.AOG.0000192397.41191.fb","volume":"107","author":"C Mao","year":"2006","unstructured":"Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, Alvarez FB, Bautista OM, Jansen KU, Barr E: Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol. 2006, 107 (1): 18-27.","journal-title":"Obstet Gynecol"},{"issue":"9518","key":"1275_CR40","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","volume":"367","author":"DM Harper","year":"2006","unstructured":"Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G: Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006, 367 (9518): 1247-1255. 10.1016\/S0140-6736(06)68439-0.","journal-title":"Lancet"},{"issue":"9490","key":"1275_CR41","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","volume":"366","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, et al: Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005, 366 (9490): 991-998. 10.1016\/S0140-6736(05)67069-9.","journal-title":"Lancet"},{"issue":"3 Suppl","key":"1275_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1054-139X(01)00296-8","volume":"29","author":"SH Vermund","year":"2001","unstructured":"Vermund SH, Wilson CM, Rogers AS, Partlow C, Moscicki AB: Sexually transmitted infections among HIV infected and HIV uninfected high-risk youth in the REACH study. Reaching for Excellence in Adolescent Care and Health. J Adolesc Health. 2001, 29 (3 Suppl): 49-56. 10.1016\/S1054-139X(01)00296-8.","journal-title":"J Adolesc Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-10-295\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-295","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T10:37:19Z","timestamp":1559731039000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-10-295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,14]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1275"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-10-295","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,14]]},"article-number":"295"}}